RiNA, 5 PRIME Take Over Roche’s RTS Protein-Expression Portfolio
Roche and RiNA have agreed to transfer the Roche Applied Science RTS Protein Expression portfolio to German company, RiNA, effective September 15, 2009. Under the agreement, RiNA will

Roche and RiNA have agreed to transfer the Roche Applied Science RTS Protein Expression portfolio to German company, RiNA, effective September 15, 2009. Under the agreement, RiNA will

Vical has received $2.5m installment payment from AnGes for the company’s ongoing Allovectin-7 phase 3 metastatic melanoma trial. Reportedly, through a series of cash payments and equity investments

Vaxart has been awarded a $2.8m phase II Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease (NIH) to support development of its

DOR BioPharma (DOR) has reported that the National Institutes of Health (NIH) has awarded DOR a Small Business Innovation Research (SBIR) grant to support the conduct of a

Word Health Organisation has authorised DCGI to issue Pharmaceutical Product (Copp) and good manufacturing practice (GMP) certificates, starting October 1, reported TopNews. The step is expected to streamline

Ipsen and Debiopharm has signed an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen’s first-in-class inhibitor of the CDC25 phosphatase enzyme

Pfizer on Friday announced that it has plans to launch two or three generic drugs in India by December, reported Indiainfoline. It is an attempt to boost sales

Stemedica Cell Technologies has signed an agreement for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement

Chugai Pharmaceutical has announced to increase the supply of the anti-influenza drug Tamiflu Capsule 75 and Tamiflu Dry Syrup 3% (oseltamivir phosphate) imported from F Hoffmann-La Roche for

Aurobindo Pharma (Aurobindo) has received two approvals from Swissmedic, Government of Switzerland for the license of Amlodipine APL 5mg and 10mg tablets and Metformin APL 500mg, 850mg and